ArticleJHLT openPublished
Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- JHLT open
- Published
- Topic
- Clinical care
- Subject terms
- Mortality; Survival; Endothelin receptor antagonist; Pulmonary Arterial Hypertension; Phosphodiesterase-5 Inhibitor; Macitentan; Upfront Combination Therapy
- PubMed ID
- 41568020
- PubMed Central ID
- PMC12818237
- Open access
- Yes, open
- Added to directory
- Source checked